Ultrasound Assessment of Gluteal Muscle in Patients Receiving Depot Antipsychotics and Healthy Volunteers
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSt. Olavs Hospital
About this trial
This observational study will use ultrasound to assess the gluteal musculature in patients receiving depot antipsychotic medication and in healthy volunteers. The study aims to improve knowledge about anatomical conditions relevant to intramuscular depot injections.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
adults receiving depot antipsychotic medication and able to provide informed consent.
Disqualifiers
Acute infections at the injection site
Previous surgery that makes ultrasound examination difficult
Trial population
Adults receiving depot antipsychotic medication
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
60 Participants
are grouped into 1 trial groupGroup A: Group 1: Patients receiving depot antipsychotic medication (n=30)
Trial outcomes
Primary outcomes
1
Ultrasound-based assessment of gluteal anatomy, including measurements relevant to identifying an appropriate intramuscular injection site.
Primary outcome is skin muscle (gluteus) distanse in millimeter
Time frame
At the ultrasound examination (single study visit).Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
St. Olavs Hospital
Lead sponsor
SINTEF Health Research
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: